Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for GRRMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
November 30, 2025 1.255B
August 31, 2025 1.641B
May 31, 2025 1.635B
February 28, 2025 1.573B
November 30, 2024 1.561B
August 31, 2024 1.585B
May 31, 2024 1.606B
February 29, 2024 1.556B
November 30, 2023 1.577B
August 31, 2023 1.551B
May 31, 2023 1.547B
February 28, 2023 1.229B
November 30, 2022 1.280B
August 31, 2022 1.296B
May 31, 2022 1.228B
February 28, 2022 1.168B
November 30, 2021 1.105B
August 31, 2021 1.081B
May 31, 2021 1.115B
February 28, 2021 1.069B
November 30, 2020 1.057B
August 31, 2020 1.023B
May 31, 2020 1.020B
February 29, 2020 1.016B
November 30, 2019 1.020B
Date Value
August 31, 2019 1.115B
May 31, 2019 1.149B
February 28, 2019 1.110B
November 30, 2018 988.07M
August 31, 2018 938.01M
May 31, 2018 939.04M
February 28, 2018 960.12M
November 30, 2017 897.91M
August 31, 2017 849.64M
May 31, 2017 802.68M
February 28, 2017 798.05M
November 30, 2016 770.31M
August 31, 2016 727.89M
May 31, 2016 685.07M
February 29, 2016 669.11M
November 30, 2015 661.58M
August 31, 2015 610.51M
May 31, 2015 598.23M
February 28, 2015 621.41M
November 30, 2014 677.45M
August 31, 2014 693.36M
May 31, 2014 699.85M
February 28, 2014 708.25M
November 30, 2013 688.79M
August 31, 2013 616.73M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Sartorius AG 3.227B
SCHOTT Pharma AG & Co. KGaA 1.139B
Agilent Technologies, Inc. 7.122B
Bio-Rad Laboratories, Inc. 7.174B
Bruker Corp. 2.381B

Shareholders Equity (Quarterly) Related Metrics